Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

162644596 179419 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179419 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585580 179444 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 179444 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585418 179447 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 179447 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
148659040 179564 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
CHEMBL4741806 179564 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
153585598 179615 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4742673 179615 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
148397968 179635 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179635 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
147048009 179657 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
CHEMBL4743199 179657 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
147451915 179687 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179687 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
152956498 179710 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179710 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585490 179741 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
CHEMBL4744169 179741 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
153585688 179758 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179758 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162647825 179835 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179835 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179862 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179862 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150944515 179864 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
CHEMBL4745487 179864 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
147626442 179879 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
CHEMBL4745668 179879 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
150995037 179919 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 179919 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
162648023 179975 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4746822 179975 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585512 180028 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 180028 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 180125 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 180125 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
153585452 180211 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4749705 180211 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
151976938 180240 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 180240 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 180278 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 180278 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 180282 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 180282 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152023194 180330 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
CHEMBL4751203 180330 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
153585601 180337 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4751259 180337 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585718 180341 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 180341 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585541 180381 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 180381 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
153585550 180393 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 180393 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585655 180476 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 180476 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
147378727 180527 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 180527 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 180530 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 180530 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
150050373 180595 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
CHEMBL4754384 180595 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
149101043 180603 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180603 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180605 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180605 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180757 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180757 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585588 180786 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180786 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585712 180791 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180791 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
94095050 180811 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180811 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585575 180829 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180829 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
162656575 180883 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180883 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585415 180888 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180888 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
162656504 180896 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 180896 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585404 180908 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4757742 180908 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
149421402 180956 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 180956 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 181055 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 181055 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
153585534 181084 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 181084 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
162657416 181120 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 181120 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585663 181155 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 181155 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585574 181221 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 181221 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 181275 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 181275 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 181284 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 181284 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585643 181341 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 181341 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
147323186 181384 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 181384 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 181445 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 181445 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 181464 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 181464 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585681 181483 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764666 181483 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152494840 181497 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 181497 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181769 1 None 3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181769 1 None 3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
162665057 182066 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 182066 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
149618414 182261 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 182261 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585453 182268 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783815 182268 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585542 182306 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 182306 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151570395 182387 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
CHEMBL4785283 182387 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
153585417 182427 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 182427 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
162667558 182462 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 182462 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
153585609 182472 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 182472 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 182536 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 182536 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
151043804 182675 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182675 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182751 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182751 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150234341 182790 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4790498 182790 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
149881970 182854 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4791551 182854 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149784975 182878 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
CHEMBL4791843 182878 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
162670473 182910 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4792356 182910 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
153585679 182923 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182923 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 182944 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182944 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
153585435 182994 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4793463 182994 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585524 183130 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 183130 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585386 183233 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 183233 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 183360 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 183360 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 183392 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 183392 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
162675990 183418 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
CHEMBL4798509 183418 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
153585488 183467 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4799144 183467 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585707 183578 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 183578 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585650 179404 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4740004 179404 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162644596 179419 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179419 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179814 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179814 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146867363 179876 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4745642 179876 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 180045 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 180045 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585543 180236 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
CHEMBL4750043 180236 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
153585514 180373 0 None -10 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 180373 0 None -10 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585659 180632 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4754933 180632 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
153585592 180743 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4755986 180743 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
133916051 181249 1 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
CHEMBL4761733 181249 1 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
153065968 181278 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4762154 181278 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585680 181286 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
CHEMBL4762210 181286 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
151392727 181723 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4777046 181723 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181769 1 None 3 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181769 1 None 3 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585533 182051 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
CHEMBL4781160 182051 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
153585698 182421 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4785855 182421 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
149374815 182501 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
CHEMBL4786952 182501 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
153585657 182570 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
CHEMBL4787820 182570 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
121349628 182025 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 182025 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 182025 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 182025 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349739 182170 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 182170 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
121349631 182482 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 182482 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
122195502 124117 0 None - 1 Human 5.0 pEC50 = 5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633717 124117 0 None - 1 Human 5.0 pEC50 = 5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349564 181764 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181764 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181764 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181764 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349633 182717 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182717 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
164628435 186290 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 186290 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
26532940 124120 1 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633721 124120 1 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164621186 186094 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 186094 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181846 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181846 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349566 182652 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182652 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349806 183374 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 183374 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
2114212 20930 14 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL1310918 20930 14 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
121349764 182888 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
CHEMBL4792090 182888 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
36428174 181942 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 181942 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349734 182096 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 182096 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349683 182723 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182723 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349710 182948 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 182948 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349767 183330 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 183330 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2303171 124119 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633719 124119 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349643 183446 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
CHEMBL4798899 183446 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
164611430 185224 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 185224 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349781 181848 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181848 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349675 181965 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 181965 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349763 182468 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4786501 182468 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
121349809 183161 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 183161 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349689 183219 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 183219 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
2548547 2149 45 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
8766 2149 45 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
CHEMBL3633720 2149 45 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
1555702 124118 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633718 124118 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349597 181811 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181811 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349786 182253 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 182253 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
28918448 124139 3 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633895 124139 3 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349574 182819 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182819 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182819 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182819 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349782 183044 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 183044 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
121349740 182091 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 182091 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349745 182212 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 182212 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 182212 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 182212 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
121349593 182873 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182873 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
40719079 124131 1 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633885 124131 1 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349656 183489 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 183489 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349786 182253 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 182253 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349593 182873 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182873 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
2695546 186116 12 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 186116 12 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
2548543 124140 2 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633896 124140 2 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
11685 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
2714485 182942 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
CHEMBL4792727 182942 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
121349719 183259 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349719 183259 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 183259 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 183259 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
8036946 183439 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 183439 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349614 181665 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181665 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
27783537 181683 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
CHEMBL4776509 181683 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
121349728 181816 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181816 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181816 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181816 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
41757362 182213 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 182213 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349658 182703 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182703 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
27785340 183471 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 183471 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27754276 185931 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 185931 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
7534868 124124 2 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633878 124124 2 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
122195644 124134 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633888 124134 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349701 181944 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 181944 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349805 183120 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 183120 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
121349755 181803 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181803 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349734 182096 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 182096 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
27785340 183471 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 183471 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
122195501 124116 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633716 124116 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
8036887 184740 1 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184740 1 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349639 182417 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349639 182417 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 182417 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 182417 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
3341369 47645 7 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1546963 47645 7 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349694 182215 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 182215 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 182215 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 182215 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349596 183441 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 183441 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164609046 184485 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 184485 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349780 186369 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 186369 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349738 182097 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 182097 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349572 181846 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181846 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2109722 124136 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633890 124136 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349658 182703 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182703 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349548 183429 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 183429 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
8036946 183439 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 183439 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
26810968 186283 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 186283 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
28918445 124127 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633881 124127 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349633 182717 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182717 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349767 183330 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 183330 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
121349559 181836 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181836 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
121349615 183125 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 183125 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349746 183384 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 183384 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349645 181718 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181718 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349720 182243 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 182243 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
122195642 124132 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633886 124132 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349688 182898 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 182898 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349659 182265 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 182265 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349600 182585 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 182585 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
3376937 124137 50 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633893 124137 50 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
122195500 124115 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633715 124115 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349746 183384 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 183384 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
2496250 28952 7 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28952 7 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
122195640 124129 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633883 124129 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195643 124133 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633887 124133 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349558 181972 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 181972 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
121349685 182133 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 182133 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349623 182100 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 182100 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349588 182236 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 182236 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349773 182428 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 182428 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349793 181823 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4778263 181823 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
122195639 124128 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633882 124128 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195641 124130 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633884 124130 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
2714528 182478 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 182478 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
2714527 185405 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 185405 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349679 186268 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 186268 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
28821961 124126 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633880 124126 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349685 182133 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 182133 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
122195638 124125 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633879 124125 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349795 183449 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 183449 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
27838947 185431 2 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 185431 2 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
2998350 38104 6 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
CHEMBL1460960 38104 6 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
122195499 124114 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633714 124114 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
41757362 182213 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 182213 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349753 182894 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 182894 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
2856847 124138 10 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633894 124138 10 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164619649 185766 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185766 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
121349671 181753 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181753 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349778 182356 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 182356 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349756 182567 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 182567 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349555 182637 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4788631 182637 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349787 182672 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182672 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349554 183539 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 183539 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
164617704 184531 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847795 184531 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164617980 185029 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 185029 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
122195645 124135 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633889 124135 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
78596259 185375 1 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 185375 1 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349587 182412 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 182412 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
164620660 185945 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869485 185945 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
27783537 181683 1 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181683 1 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349569 181915 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 181915 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349561 182730 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182730 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 182927 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 182927 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349596 183441 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 183441 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
164620725 186085 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 186085 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
36428174 181942 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 181942 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349753 182894 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 182894 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
11685 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 4139 25 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2144 2356 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
3313 2356 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6140 2356 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6925665 2356 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
CHEMBL301523 2356 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
DB00120 2356 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
2780 2373 106 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6305 2373 106 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6923516 2373 106 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
717 2373 106 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
CHEMBL54976 2373 106 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
DB00150 2373 106 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
7799 1011 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
86277840 1011 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
2144 2356 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
3313 2356 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6140 2356 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6925665 2356 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
CHEMBL301523 2356 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
DB00120 2356 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
2780 2373 106 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6305 2373 106 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6923516 2373 106 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
717 2373 106 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
CHEMBL54976 2373 106 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
DB00150 2373 106 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
12363 2751 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
5348723 2751 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
2144 2356 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2356 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2356 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2356 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2356 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2356 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2373 106 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2373 106 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2373 106 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2373 106 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2373 106 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2373 106 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
789353 2354 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
8774 2354 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
5017692 2750 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661
8775 2750 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

153585580 179444 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 179444 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
148397968 179635 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179635 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585666 179637 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4742949 179637 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
147451915 179687 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179687 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585625 179693 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
CHEMBL4743662 179693 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
153585420 179810 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179810 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
153585722 179947 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4746401 179947 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
162649907 180083 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4748076 180083 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
152844759 180099 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 180099 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585686 180253 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 180253 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147641221 180296 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 180296 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 180341 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 180341 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 180362 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 180362 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585708 180457 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4752808 180457 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
153585648 180517 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753388 180517 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162653764 180533 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753640 180533 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585540 180608 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180608 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585467 180609 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4754576 180609 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
152015494 180623 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4754735 180623 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150352344 180771 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756243 180771 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
162655689 180783 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4756356 180783 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585712 180791 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180791 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180888 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180888 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585630 180995 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
CHEMBL4758841 180995 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
153585534 181084 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 181084 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585651 181202 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761154 181202 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 181276 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 181276 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
162659465 181320 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4762651 181320 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585610 181445 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 181445 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
153585689 181506 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
CHEMBL4764967 181506 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
162661302 181517 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 181517 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585427 181981 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
CHEMBL4780358 181981 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
153585638 182200 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4782901 182200 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585409 182471 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4786542 182471 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
147410414 182681 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182681 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
153585385 182817 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182817 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
162671538 182829 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4791193 182829 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162671011 182944 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182944 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 182955 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 182955 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151533016 182970 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4793093 182970 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585429 183412 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 183412 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585699 183501 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4799647 183501 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585528 183564 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 183564 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
162644596 179419 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179419 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585418 179447 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 179447 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585684 179533 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4741467 179533 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
152956498 179710 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179710 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585688 179758 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179758 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162648790 179787 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179787 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585420 179810 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179810 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162647825 179835 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179835 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179862 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179862 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150995037 179919 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 179919 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585512 180028 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 180028 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 180125 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 180125 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
151976938 180240 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 180240 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585686 180253 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 180253 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147634500 180278 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 180278 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
147641221 180296 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 180296 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 180341 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 180341 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585721 180351 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751414 180351 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 180362 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 180362 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585514 180373 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 180373 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585541 180381 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 180381 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
162653366 180460 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 180460 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
153585655 180476 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 180476 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
153585421 180521 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4753419 180521 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
147378727 180527 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 180527 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 180530 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 180530 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
148512747 180557 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4753915 180557 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
149101043 180603 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180603 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180605 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180605 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585540 180608 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180608 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180757 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180757 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
94095050 180811 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180811 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657043 180822 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4756879 180822 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
162656575 180883 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180883 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
162656504 180896 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 180896 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
152460205 180934 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758096 180934 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585448 180950 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4758322 180950 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149421402 180956 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 180956 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 181055 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 181055 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
162657416 181120 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 181120 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
150924716 181166 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4760914 181166 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585574 181221 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 181221 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 181275 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 181275 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 181276 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 181276 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
147987797 181284 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 181284 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
147323186 181384 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 181384 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 181445 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 181445 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 181464 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 181464 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
152494840 181497 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 181497 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162661302 181517 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 181517 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585547 181741 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181741 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181830 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181830 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 182066 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 182066 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
150561998 182131 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4782195 182131 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
149618414 182261 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 182261 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585463 182407 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4785639 182407 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
153585417 182427 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 182427 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
153585609 182472 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 182472 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 182536 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 182536 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585701 182553 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4787547 182553 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151043804 182675 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182675 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182751 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182751 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585385 182817 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182817 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
153585679 182923 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182923 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 182944 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182944 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 182955 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 182955 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585524 183130 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 183130 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585504 183211 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4795956 183211 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585386 183233 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 183233 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 183360 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 183360 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 183392 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 183392 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
153585429 183412 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 183412 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585528 183564 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 183564 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
153585707 183578 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 183578 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
162644596 179419 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179419 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648790 179787 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179787 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
162647825 179835 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179835 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
162649809 180045 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 180045 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
151976938 180240 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 180240 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 180278 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 180278 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 180282 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 180282 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162653366 180460 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 180460 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
162653797 180530 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 180530 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
152007746 180566 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 180566 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585713 180971 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
CHEMBL4758561 180971 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
153585574 181221 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 181221 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 181284 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 181284 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
162661581 181464 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 181464 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585547 181741 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181741 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181830 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181830 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 182066 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 182066 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151043804 182675 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182675 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585679 182923 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182923 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162670606 182938 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4792682 182938 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
153585386 183233 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 183233 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585532 183392 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 183392 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
147477854 183498 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4799618 183498 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
162644596 179419 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179419 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179814 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179814 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146976458 180030 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4747440 180030 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 180045 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 180045 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
152844759 180099 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 180099 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585550 180393 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 180393 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
152007746 180566 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 180566 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585588 180786 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180786 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585575 180829 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180829 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180888 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180888 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585534 181084 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 181084 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585663 181155 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 181155 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585643 181341 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 181341 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181769 1 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181769 1 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585542 182306 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 182306 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162667558 182462 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 182462 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
147410414 182681 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182681 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
121349671 181753 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181753 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349806 183374 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 183374 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349656 183489 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 183489 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349756 182567 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 182567 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
27785340 183471 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 183471 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27785340 183471 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 183471 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
121349782 183044 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 183044 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
164619649 185766 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185766 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
26810968 186283 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 186283 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
11685 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349786 182253 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 182253 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349639 182417 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 182417 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349786 182253 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 182253 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
121349639 182417 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 182417 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
2695546 186116 12 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 186116 12 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349600 182585 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 182585 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
121349548 183429 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 183429 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349548 183429 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798667 183429 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349554 183539 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 183539 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
36428174 181942 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 181942 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
36428174 181942 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 181942 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349659 182265 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 182265 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349593 182873 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182873 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349593 182873 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182873 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
121349633 182717 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182717 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349633 182717 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182717 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
2714527 185405 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 185405 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
2714528 182478 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 182478 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
27838947 185431 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 185431 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
121349658 182703 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182703 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
121349658 182703 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182703 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349597 181811 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181811 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349631 182482 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4786722 182482 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349631 182482 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 182482 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349615 183125 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 183125 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349564 181764 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181764 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181764 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181764 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349588 182236 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 182236 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349572 181846 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181846 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181846 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181846 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349778 182356 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 182356 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
164617980 185029 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 185029 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
121349738 182097 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 182097 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349559 181836 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181836 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
164628435 186290 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 186290 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
8036946 183439 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 183439 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
8036946 183439 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 183439 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
121349701 181944 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 181944 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349710 182948 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 182948 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349675 181965 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 181965 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349683 182723 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182723 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349753 182894 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 182894 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
121349753 182894 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 182894 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
78596259 185375 1 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 185375 1 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349739 182170 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 182170 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
2496250 28952 7 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28952 7 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349685 182133 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 182133 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349685 182133 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 182133 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349719 183259 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 183259 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
121349787 182672 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182672 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349623 182100 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 182100 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349755 181803 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181803 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349773 182428 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 182428 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349614 181665 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181665 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
121349720 182243 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 182243 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
121349645 181718 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181718 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
164611430 185224 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 185224 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349746 183384 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 183384 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349746 183384 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 183384 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349745 182212 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 182212 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 182212 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 182212 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
8036887 184740 1 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184740 1 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349781 181848 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181848 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349596 183441 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 183441 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349596 183441 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 183441 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349728 181816 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181816 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181816 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181816 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
121349688 182898 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 182898 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
27783537 181683 1 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181683 1 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349587 182412 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 182412 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 182927 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 182927 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349689 183219 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 183219 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349780 186369 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 186369 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349628 182025 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 182025 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 182025 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 182025 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349805 183120 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 183120 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
27754276 185931 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 185931 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
121349734 182096 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 182096 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
121349734 182096 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 182096 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349574 182819 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182819 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182819 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182819 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349569 181915 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 181915 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
164609046 184485 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 184485 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349561 182730 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182730 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349719 183259 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 183259 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349711 182867 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
CHEMBL4791752 182867 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
121349694 182215 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 182215 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 182215 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 182215 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349679 186268 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 186268 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349566 182652 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182652 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
164621186 186094 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 186094 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 183330 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 183330 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 183330 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 183330 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
164620725 186085 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 186085 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349809 183161 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 183161 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349740 182091 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 182091 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349795 183449 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 183449 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349558 181972 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 181972 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
41757362 182213 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 182213 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
41757362 182213 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 182213 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
2144 2356 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2356 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2356 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2356 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2356 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2356 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2373 106 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2373 106 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2373 106 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2373 106 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2373 106 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2373 106 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
11685 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 4139 25 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2548547 2149 45 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
8766 2149 45 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
CHEMBL3633720 2149 45 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500